Prudential Financial Inc. Boosts Stake in Pediatrix Medical Group, Inc. (NYSE:MD)

Prudential Financial Inc. boosted its position in Pediatrix Medical Group, Inc. (NYSE:MD) by 6.1% in the 4th quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission (SEC). The fund owned 808,658 shares of the company’s stock after purchasing an additional 46,635 shares during the period. Prudential Financial Inc. owned approximately 0.94% of Pediatrix Medical Group worth $10,610,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

Several other large investors have also modified their holdings of the business. Quest Partners LLC lifted its stake in shares of Pediatrix Medical Group by 25.6% during the 3rd quarter. Quest Partners LLC now owns 3,054 shares of the company’s stock worth $35,000 after acquiring an additional 622 shares during the last quarter. Intech Investment Management LLC lifted its position in shares of Pediatrix Medical Group by 29.6% during the third quarter. Intech Investment Management LLC now owns 40,662 shares of the company’s stock worth $471,000 after purchasing an additional 9,289 shares during the last quarter. Algert Global LLC bought a new stake in shares of Pediatrix Medical Group during the third quarter worth $1,315,000. FMR LLC boosted its stake in shares of Pediatrix Medical Group by 220.6% during the third quarter. FMR LLC now owns 9,841 shares of the company’s stock valued at $114,000 after purchasing an additional 6,771 shares during the period. Finally, BNP Paribas Financial Markets grew its holdings in shares of Pediatrix Medical Group by 141.2% in the third quarter. BNP Paribas Financial Markets now owns 18,520 shares of the company’s stock worth $215,000 after purchasing an additional 10,843 shares during the last quarter. Hedge funds and other institutional investors own 97.71% of the company’s stock.

Pediatrix Medical Group Stock Performance

Shares of Pediatrix Medical Group stock opened at $14.15 on Friday. The company has a 50 day moving average price of $14.40 and a 200 day moving average price of $13.65. The firm has a market capitalization of $1.21 billion, a P/E ratio of -11.79, a PEG ratio of 1.74 and a beta of 1.49. The company has a quick ratio of 1.42, a current ratio of 1.60 and a debt-to-equity ratio of 0.81. Pediatrix Medical Group, Inc. has a 52 week low of $6.62 and a 52 week high of $17.67.

Pediatrix Medical Group (NYSE:MD) last posted its quarterly earnings results on Thursday, February 20th. The company reported $0.49 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $0.37 by $0.12. The business had revenue of $502.36 million during the quarter, compared to analysts’ expectations of $486.22 million. Pediatrix Medical Group had a negative net margin of 4.92% and a positive return on equity of 15.47%. Sell-side analysts expect that Pediatrix Medical Group, Inc. will post 1.38 EPS for the current year.

Wall Street Analysts Forecast Growth

MD has been the subject of several research reports. StockNews.com raised shares of Pediatrix Medical Group from a “hold” rating to a “buy” rating in a research report on Wednesday, January 22nd. Truist Financial upped their target price on Pediatrix Medical Group from $15.00 to $18.00 and gave the stock a “hold” rating in a report on Friday, February 21st. UBS Group lifted their price target on Pediatrix Medical Group from $16.50 to $18.50 and gave the company a “neutral” rating in a report on Friday, February 21st. Finally, Macquarie initiated coverage on Pediatrix Medical Group in a research note on Monday, December 16th. They set an “outperform” rating and a $18.00 price objective for the company. Four equities research analysts have rated the stock with a hold rating and three have issued a buy rating to the stock. According to MarketBeat, Pediatrix Medical Group presently has a consensus rating of “Hold” and a consensus target price of $17.08.

Pediatrix Medical Group Company Profile

Pediatrix Medical Group, Inc, together with its subsidiaries, provides newborn, maternal-fetal, pediatric cardiology, and other pediatric subspecialty care services in the United States. It offers neonatal care services, such as clinical care to babies born prematurely or with complications within specific units at hospitals through neonatal physician subspecialists, neonatal nurse practitioners, and other pediatric clinicians.